Annual Total Debt
$266.17 M
+$5.22 M+2.00%
December 31, 2023
Summary
- As of February 7, 2025, ESPR annual total debt is $266.17 million, with the most recent change of +$5.22 million (+2.00%) on December 31, 2023.
- During the last 3 years, ESPR annual total debt has risen by +$80.76 million (+43.56%).
- ESPR annual total debt is now at all-time high.
Performance
ESPR Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$268.96 M
-$173.00 K-0.06%
September 30, 2024
Summary
- As of February 7, 2025, ESPR quarterly total debt is $268.96 million, with the most recent change of -$173.00 thousand (-0.06%) on September 30, 2024.
- Over the past year, ESPR quarterly total debt has dropped by -$173.00 thousand (-0.06%).
- ESPR quarterly total debt is now -2.75% below its all-time high of $276.55 million, reached on March 31, 2021.
Performance
ESPR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ESPR Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.0% | -0.1% |
3 y3 years | +43.6% | -0.1% |
5 y5 years | +100.0% | +10000.0% |
ESPR Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +2.3% | -0.1% | +3.4% |
5 y | 5-year | at high | >+9999.0% | -2.8% | >+9999.0% |
alltime | all time | at high | -100.0% | -2.8% | -100.0% |
Esperion Therapeutics Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $268.96 M(-0.1%) |
Jun 2024 | - | $269.13 M(+0.1%) |
Mar 2024 | - | $268.99 M(+1.1%) |
Dec 2023 | $266.17 M(+2.0%) | $266.17 M(+0.8%) |
Sep 2023 | - | $264.13 M(+0.4%) |
Jun 2023 | - | $263.13 M(+0.7%) |
Mar 2023 | - | $261.40 M(+0.2%) |
Dec 2022 | $260.95 M(+0.3%) | $260.95 M(+0.3%) |
Sep 2022 | - | $260.23 M(+0.0%) |
Jun 2022 | - | $260.17 M(+0.0%) |
Mar 2022 | - | $260.16 M(-0.0%) |
Dec 2021 | $260.20 M(+40.3%) | $260.20 M(-5.8%) |
Sep 2021 | - | $276.22 M(-0.1%) |
Jun 2021 | - | $276.36 M(-0.1%) |
Mar 2021 | - | $276.55 M(+49.2%) |
Dec 2020 | $185.41 M(>+9900.0%) | $185.41 M(+2652.5%) |
Sep 2020 | - | $6.74 M(+8.7%) |
Jun 2020 | - | $6.20 M(+10.1%) |
Mar 2020 | - | $5.63 M(+260.3%) |
Dec 2019 | $1.56 M(>+9900.0%) | $1.56 M(+43.8%) |
Sep 2019 | - | $1.09 M(+13.5%) |
Jun 2019 | - | $958.00 K(-1.8%) |
Mar 2019 | - | $976.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(-100.0%) |
Jun 2018 | - | $152.00 K(-74.8%) |
Mar 2018 | - | $603.00 K(-42.3%) |
Dec 2017 | $1.04 M | $1.04 M(-29.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2017 | - | $1.48 M(-22.3%) |
Jun 2017 | - | $1.90 M(-18.0%) |
Mar 2017 | - | $2.32 M(-15.0%) |
Dec 2016 | $2.73 M(-36.4%) | $2.73 M(-12.8%) |
Sep 2016 | - | $3.13 M(-11.2%) |
Jun 2016 | - | $3.53 M(-9.8%) |
Mar 2016 | - | $3.91 M(-8.9%) |
Dec 2015 | $4.29 M(-11.9%) | $4.29 M(-7.9%) |
Sep 2015 | - | $4.66 M(-4.9%) |
Jun 2015 | - | $4.90 M(+0.3%) |
Mar 2015 | - | $4.88 M(+0.3%) |
Dec 2014 | $4.87 M(>+9900.0%) | $4.87 M(-1.2%) |
Sep 2014 | - | $4.93 M(+0.1%) |
Jun 2014 | - | $4.92 M(>+9900.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(-100.0%) |
Dec 2012 | $22.77 M(+230.1%) | $22.77 M(>+9900.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00 |
Dec 2011 | $6.90 M(-21.6%) | - |
Dec 2002 | $8.79 M(+38.6%) | - |
Dec 2001 | $6.34 M(+70.4%) | - |
Dec 2000 | $3.72 M(+34.0%) | - |
Dec 1999 | $2.78 M | - |
FAQ
- What is Esperion Therapeutics annual total debt?
- What is the all time high annual total debt for Esperion Therapeutics?
- What is Esperion Therapeutics annual total debt year-on-year change?
- What is Esperion Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly total debt year-on-year change?
What is Esperion Therapeutics annual total debt?
The current annual total debt of ESPR is $266.17 M
What is the all time high annual total debt for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total debt is $266.17 M
What is Esperion Therapeutics annual total debt year-on-year change?
Over the past year, ESPR annual total debt has changed by +$5.22 M (+2.00%)
What is Esperion Therapeutics quarterly total debt?
The current quarterly total debt of ESPR is $268.96 M
What is the all time high quarterly total debt for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total debt is $276.55 M
What is Esperion Therapeutics quarterly total debt year-on-year change?
Over the past year, ESPR quarterly total debt has changed by -$173.00 K (-0.06%)